» Articles » PMID: 17912702

Dimethylsphingosine and FTY720 Inhibit the SK1 Form but Activate the SK2 Form of Sphingosine Kinase from Rat Heart

Overview
Publisher Wiley
Date 2007 Oct 4
PMID 17912702
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Fractionation of cytosolic sphingosine kinase (SKase) activity by gel filtration chromatography gave rise to a 96-kDa peak that contained only the SK2 form of SKase (by Western analysis) and a broad ca. 46 kDa peak that contained only SK1 forms. SK2 appeared to have a bound accessory protein. When tested with the classic SKase inhibitor dimethylsphingosine (DMS), SK1 was extensively inhibited; however, SK2 was not inhibited but unexpectedly was activated. Activation of SK2 was the result of DMS enhancing the affinity of the enzyme for sphingosine, and, at low concentrations of ATP and sphingosine, activated by more than 100%. Activation of SK2 could be demonstrated in the cytosolic fraction indicating it was unrelated to the purification step. The immunomodulator FTY720 also activated SK2 (although to a lesser extent), but was a potent inhibitor of SK1. SK2 from rat liver and spleen was also not inhibited by DMS. L-Sphingosine and to a lesser extent dihydrosphingosine and phytosphingosine were effective inhibitors of both forms.

Citing Articles

Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod.

Pournajaf S, Dargahi L, Javan M, Pourgholami M Front Pharmacol. 2022; 13:807639.

PMID: 35250559 PMC: 8889014. DOI: 10.3389/fphar.2022.807639.


Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters.

Gomez-Brouchet A, Illac C, Ledoux A, Fortin P, De Barros S, Vabre C Cancers (Basel). 2022; 14(3).

PMID: 35158767 PMC: 8833796. DOI: 10.3390/cancers14030499.


Lysosome‑targeted drug combination induces multiple organelle dysfunctions and non‑canonical death in pancreatic cancer cells.

Suzuki S, Ogawa M, Miyazaki M, Ota K, Kazama H, Hirota A Oncol Rep. 2021; 47(2).

PMID: 34958115 PMC: 8759104. DOI: 10.3892/or.2021.8251.


Increased Sphingosine-1-Phosphate Serum Concentrations in Subjects with Periodontitis: A Matter of Inflammation.

Moritz E, Jedlitschky G, Negnal J, Tzvetkov M, Daum G, Dorr M J Inflamm Res. 2021; 14:2883-2896.

PMID: 34234513 PMC: 8256099. DOI: 10.2147/JIR.S302117.


Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of phingosine Kinase 1.

Roy S, Mahapatra A, Mohammad T, Gupta P, Alajmi M, Hussain A Pharmaceuticals (Basel). 2020; 13(6).

PMID: 32526899 PMC: 7346089. DOI: 10.3390/ph13060118.